One thing is surer than ever, many policy experts say: Beneficiaries should not simply roll over their existing stand-alone Medicare drug plans. Original article: https://www.reviewjournal.com/livewell/heres-why-medicare-part-d-premiums-are-likely-to-go-up-3428401/
